CASI Pharmaceuticals
CASI
CASI was delisted on the 25th of February, 2026.
59 hedge funds and large institutions have $57.2M invested in CASI Pharmaceuticals in 2020 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 27 increasing their positions, 13 reducing their positions, and 6 closing their positions.
108% more repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 13
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
29% more capital invested
Capital invested by funds: $44.4M → $57.2M (+$12.8M)
17% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 6
2% more funds holding
Funds holding: 58 → 59 (+1)
0.07% more ownership
Funds ownership: 2.2% → 2.27% (+0.07%)
Top Buyers
| 1 |
WSC
Wellington Shields & Co
New York
|
+$587K |
| 2 |
BlackRock
New York
|
+$486K |
| 3 |
Northern Trust
Chicago,
Illinois
|
+$385K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$348K |
| 5 |
Wells Fargo
San Francisco,
California
|
+$211K |
Top Sellers
| 1 |
Citadel Advisors
Miami,
Florida
|
-$66.2K |
| 2 |
First Manhattan
New York
|
-$61K |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$44K |
| 4 |
VIA
Vident Investment Advisory
Alpharetta,
Georgia
|
-$39.2K |
| 5 |
Goldman Sachs
New York
|
-$38K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AIP
51
Ameritas Investment Partners
Lincoln,
Nebraska
| $11K | – | – | – |
|
52
BNP Paribas Financial Markets
Paris,
France
| $10.6K | -$24.4K | -1,122 | -73% |
|
53
Bank of Montreal
Toronto,
Ontario, Canada
| $10K | +$9.34K | +430 | New |
|
54
Osaic Holdings
Scottsdale,
Arizona
| $5K | – | – | – |
|
55
CAPTRUST Financial Advisors
Raleigh,
North Carolina
| $4K | +$3.26K | +150 | New |
|
|
MAM
56
Meeder Asset Management
Dublin,
Ohio
| $3K | – | – | – |
|
|
57
First Manhattan
New York
| – | -$61K | -3,000 | Closed |
|
58
Victory Capital Management
San Antonio,
Texas
| – | -$30K | -1,502 | Closed |
|
|
WIP
59
Wellesley Investment Partners
Wellesley,
Massachusetts
| – | -$30K | -1,500 | Closed |
|
60
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$29K | -1,422 | Closed |
|
|
WJWM
61
Williams Jones Wealth Management
New York
| – | -$28K | -1,375 | Closed |
|
|
PAG
62
Private Advisor Group
Morristown,
New Jersey
| – | +$304 | +14 | New |
|
CASI Hedge Fund Activity: Q2 2020 in Review
59 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in CASI Pharmaceuticals (CASI) for Q2 2020, worth a combined $57.2M — up 29% from $44.4M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new CASI positions and 6 closed out — a net gain of 1 holder — while 27 added to existing stakes and 13 trimmed.
The largest buyer was Wellington Shields & Co, adding an estimated $587K. The largest seller was Citadel Advisors, cutting an estimated $66.2K.
- 59 institutional investors held CASI Pharmaceuticals (CASI) as of Q2 2020, up from 58 in Q1 2020.
- Funds reported $57.2M of CASI Pharmaceuticals stock for Q2 2020, up 29% quarter-over-quarter.
- 7 funds opened new CASI Pharmaceuticals positions in Q2 2020 and 6 closed out, a net change of +1 holder.
- The largest CASI Pharmaceuticals buyer in Q2 2020 was Wellington Shields & Co, an estimated $587K added.
- The largest CASI Pharmaceuticals seller in Q2 2020 was Citadel Advisors, an estimated $66.2K sold.
Based on aggregated 13F filings for Q2 2020.